Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / AB Mauri (UK) Limited,

Clinicaltrial registered27 Oct 2026

AB Mauri (UK) Limited,

27 Oct 2026: Trial registered · A Study to Evaluate the Effects of a Supplement on Gut Comfort in GLP-1 Receptor Agonist Users. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
27 Oct 2026
Title
A Study to Evaluate the Effects of a Supplement on Gut Comfort in GLP-1 Receptor Agonist Users
Conditions
Gastrointestinal Discomfort, Gastrointestinal Side Effects of GLP-1 Receptor Agonist Use, Nausea, Abdominal Pain
Phase
Not applicable
Study Type
Interventional
Status
Completed
Countries
United States
Country
United States
Reference
NCT07898189
Location
United States
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at AB Mauri (UK) Limited,

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from United States

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.